Proteus Digital Health’s ingestible sensor, an adherence tool that’s been successfully tested before in patients with diabetes and heart failure, also has utility for those on psych meds, a study ...
Proteus Digital Health’ pitch to track adherence using sensor-equipped pills has found another audience in the HIV prevention community. Among the featured data presented at this week’s International ...
Proteus Digital Health gained FDA de novo clearance for a new ingestible sensor designed to be combined with a drug, capping a four-year process of working with regulators to find the best approval ...
Oracle has expanded its move into pharmaceutical innovation by investing an undisclosed “minor” sum in Proteus Digital Health, a company that has developed ingestible and wearable sensors. Proteus’ ...
Digital medicine company Proteus Digital Health has raised an additional $52 million from undisclosed investors following a whopping $120 million raise the company announced just last month. That ...
Proteus’s sensors attach to the pills patients swallow-and then tell doctors how their bodies respond.. Yudi Ela; Prop styling: Astrid Chastka/Hello Artists Many people forget to take their pills or ...
Proteus Digital Health Inc. and Otsuka Pharmaceutical Co. say they are committed to resolving concerns that led Food and Drug Administration officials to decline to approve a digital medicine that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback